Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesWellfully Ltd

Wellfully Ltd

Healthcare Diagnostics & Research
PortfolioPortfolio WatchlistWatchlist
Company price
None AUD 0.00(0%)
Last update at 2025-09-01T06:45:03.131368Z
Market Cap
1.48M

Momentum Score

…

Wellfully Limited, together with its subsidiaries, engages in the research and development of Dermaportation and ETP transdermal drug delivery technologies. The company operates through two segments, Dermaportation Drug Delivery Technology and Devices. It is involved in the industrialization and supply-chain support for its existing product ranges; and sale and marketing of its own brands REDUIT and SWISSWELL, as well as third-party collaborations. It serves the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors. The company was formerly known as OBJ Limited and changed its name to Wellfully Limited in September 2020. Wellfully Limited was incorporated in 1992 and is based in Leederville, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
1.31M
Revenue Per Share
0.00
Gross Profit TTM
0.50M
Debt / Equity
-0.18
ROE
-597.88%
Net Debt
0.04M
ROCE
400.55%
Diluted EPS TTM
-0.03

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -6.35M -8.07M -6.40M -3.57M -1.71M
Net income -6.35M -8.07M -6.40M -3.57M -1.71M
Selling general administrative 2.28M 3.90M 4.03M 2.83M 2.53M
Selling and marketing expenses 1.23M 2.47M 0.99M 0.17M -
Gross profit -0.15M 0.79M -0.42M 0.30M 1.18M
Reconciled depreciation 0.11M 0.18M 0.09M 0.07M 0.07M
Ebit -6.50M -8.03M -6.37M -3.69M -1.67M
Ebitda -6.39M -7.85M -6.29M -3.64M -1.60M
Depreciation and amortization 0.11M 0.18M 0.09M 0.05M 0.07M
Operating income -6.50M -8.69M -6.73M -3.90M -1.70M
Other operating expenses 8.01M 11.29M 7.19M 4.84M 4.41M
Interest expense - 0.06M 0.02M 0.08M 0.01M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income 0.15M 0.63M 0.38M 0.08M 0.04M
Net interest income - 0.00M -0.02M 0.09M 0.04M
Income tax expense - - - 0.37M 1.43M
Total revenue 1.51M 2.60M 0.46M 0.57M 1.25M
Total operating expenses 6.36M 9.49M 6.31M 4.57M 4.35M
Cost of revenue 1.65M 1.81M 0.88M 0.27M 0.07M
Total other income expense net 0.15M 1.16M 0.33M 0.19M 1.46M
Net income from continuing ops -6.35M -8.07M -6.40M -3.71M -1.71M
Net income applicable to common shares -6.35M -7.30M -6.40M -3.71M -1.71M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 3.49M 2.62M 3.39M 1.19M 3.14M
Other current assets -0.00M -0.09M 0.01M 0.01M -
Total liab 5.20M 2.00M 1.08M 2.41M 0.59M
Total stockholder equity -1.71M 0.62M 2.31M -1.22M 2.55M
Other current liab 0.13M 0.28M 0.37M 0.33M 0.08M
Common stock 51.72M 48.13M 42.55M 33.04M 33.04M
Capital stock 51.72M 48.13M 42.55M 33.04M 33.04M
Retained earnings -54.50M -48.91M -40.84M -34.30M -30.73M
Other liab - 0.78M - - -
Cash 0.27M 0.32M 2.73M 0.61M 2.25M
Cash and equivalents - - - - 2.25M
Total current liabilities 5.11M 1.88M 1.02M 2.40M 0.59M
Current deferred revenue 1.68M 0.15M 0.09M 0.13M -
Net debt 0.04M 0.11M -2.46M 0.39M -2.00M
Short term debt 0.22M 0.26M 0.20M 1.01M 0.25M
Short long term debt 0.18M 0.17M 0.15M 1.01M 0.25M
Short long term debt total 0.31M 0.43M 0.26M 1.01M 0.25M
Other stockholder equity - 0.77M 0.60M -0.14M 0.23M
Property plant equipment - 0.63M 0.41M 0.31M 0.32M
Total current assets 2.97M 1.99M 2.99M 0.88M 2.81M
Net tangible assets - 0.62M 2.31M -1.22M 2.55M
Short term investments - - 0.01M 0.01M -
Net receivables 0.86M 1.39M 0.16M 0.40M 0.56M
Inventory 1.84M 0.37M 0.10M - -
Accounts payable 3.07M 1.34M 0.45M 1.06M 0.26M
Accumulated other comprehensive income 1.07M 0.64M 0.60M 0.18M 0.23M
Non currrent assets other - 0.06M - 0.04M -
Non current assets total 0.52M 0.63M 0.41M 0.31M 0.32M
Capital lease obligations 0.13M 0.26M 0.11M 0.04M -
Long term debt total - 0.17M 0.06M 0.01M 0.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.11M -0.03M -0.06M 0.34M -0.02M
Change to liabilities - 0.62M -0.29M 0.40M 0.03M
Total cashflows from investing activities -0.11M -0.03M -0.06M 0.34M -0.02M
Net borrowings - -0.16M -0.03M 0.63M 0.63M
Total cash from financing activities 2.99M 5.66M 7.49M 0.65M 0.63M
Net income -6.35M -7.30M -6.40M -3.71M -1.71M
Change in cash -0.05M -2.41M 2.11M -1.64M -1.92M
Begin period cash flow 0.32M 2.73M 0.61M 2.25M 4.18M
End period cash flow 0.27M 0.32M 2.73M 0.61M 2.25M
Total cash from operating activities -2.44M -8.25M -5.20M -2.68M -1.88M
Issuance of capital stock 3.60M 6.16M 8.36M - -
Depreciation 0.11M 0.17M 0.09M 0.07M 0.07M
Other cashflows from investing activities - - - 0.34M -
Dividends paid - 0.16M 0.03M - -
Change to inventory -1.49M -0.25M -0.10M -0.10M -0.10M
Change to account receivables 0.46M -1.27M 0.12M 0.29M -0.31M
Sale purchase of stock -0.45M -0.33M -0.84M - 0.00M
Other cashflows from financing activities -0.16M -0.16M -0.03M 0.65M -0.02M
Change to netincome - -0.22M 1.38M 0.25M 0.04M
Capital expenditures 0.11M 0.03M 0.06M 0.06M 0.02M
Change in working capital 2.28M -0.90M -0.27M 0.69M -0.28M
Stock based compensation 1.27M 0.21M 1.11M - -
Other non cash items 0.24M 0.87M 1.89M 0.27M 0.04M
Free cash flow -2.55M -8.28M -5.27M -2.68M -1.90M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SHL
Sonic Healthcare Ltd		 0.09
0.45%		 19.92 16.16 17.21 0.90 1.15 1.36 8.10
IDX
Integral Diagnostics Ltd		 -
-%		 1.70 28.83 15.24 0.82 0.97 1.52 9.49
ACL
Australian Clinical Labs Ltd		 0.01
0.30%		 3.33 26.67 16.84 0.81 3.95 1.24 5.12
HLS
Healius Ltd		 0.01
2.86%		 0.54 - 29.24 0.26 2.08 0.94 10.14

Profile*

Wellfully Ltd

Wellfully Limited, together with its subsidiaries, engages in the research and development of Dermaportation and ETP transdermal drug delivery technologies. The company operates through two segments, Dermaportation Drug Delivery Technology and Devices. It is involved in the industrialization and supply-chain support for its existing product ranges; and sale and marketing of its own brands REDUIT and SWISSWELL, as well as third-party collaborations. It serves the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors. The company was formerly known as OBJ Limited and changed its name to Wellfully Limited in September 2020. Wellfully Limited was incorporated in 1992 and is based in Leederville, Australia.

284 Oxford Street, Leederville, WA, Australia, 6007

61 8 9443 3011

https://wellfully.net

Name Title Year Born
Mr. Paul Peros Exec. Chairman & CEO NA
Mr. Jeffrey David Edwards Founder, MD, Technical Director & Exec. Director NA
Mr. Sergej Dolezil Chief Financial Officer NA
Dr. Matthew McIldowie Chief Scientific Officer NA
Mr. Henko Vos C.A. Company Sec. NA
Dr. Michael Roberts Scientific Adviser NA
Mr. Paul Peros MD & CEO NA
Mr. Blagojce Pavlovski Company Secretary NA
Mr. Paul Peros MD & CEO NA
Mr. Blagojce Pavlovski Company Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…